Crunching the numbers for ROP... Refresh in a moment for the full analysis.
ROPER TECHNOLOGIES INC (ROP)
Healthcare
Deep Overvalued
healthy
$347.91
Updated: 2026-04-09
Financial Strength
50
Mixed
Operating Trend
76
Strong
Capital Allocation
45
Mixed
Fair Value
$179.97
DCF Upside
-48.3%
Sector Rank
#7
of 18
Key Findings
+
Historically cheap — EV/EBITDA in bottom 25% of its 5-year range
−
Weak liquidity — current assets below current liabilities
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.